<h4>Background</h4>Histone deacetylases (HDACs) regulate neuroprotection; however, Trichostatin A (TSA), an HDAC inhibitor, lacks clear molecular mechanisms and core targets in Alzheimer's disease (AD), limiting clinical translation. This evidence concerns the gene HDAC9 and early-onset autosomal dominant Alzheimer disease.